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DOI 10.1186/s13041-015-0097-yRESEARCH Open AccessChannel-mediated astrocytic glutamate modulates
hippocampal synaptic plasticity by activating
postsynaptic NMDA receptors
Hyungju Park1†, Kyung-Seok Han1,2†, Jinsoo Seo3†, Jaekwang Lee1†, Shashank M Dravid4, Junsung Woo1,2,
Heejung Chun1, Sukhee Cho3, Jin Young Bae5, Heeyoung An1,6, Woohyun Koh1,2, Bo-Eun Yoon1,7,
Rolando Berlinguer-Palmini8, Guido Mannaioni9, Stephen F Traynelis10, Yong Chul Bae5, Se-Young Choi3*
and C Justin Lee1,2,6*Abstract
Background: Activation of G protein coupled receptor (GPCR) in astrocytes leads to Ca2+-dependent glutamate
release via Bestrophin 1 (Best1) channel. Whether receptor-mediated glutamate release from astrocytes can regulate
synaptic plasticity remains to be fully understood.
Results: We show here that Best1-mediated astrocytic glutamate activates the synaptic N-methyl-D-aspartate receptor
(NMDAR) and modulates NMDAR-dependent synaptic plasticity. Our data show that activation of the protease-activated
receptor 1 (PAR1) in hippocampal CA1 astrocytes elevates the glutamate concentration at Schaffer collateral-CA1
(SC-CA1) synapses, resulting in activation of GluN2A-containing NMDARs and NMDAR-dependent potentiation of
synaptic responses. Furthermore, the threshold for inducing NMDAR-dependent long-term potentiation (LTP) is
lowered when astrocytic glutamate release accompanied LTP induction, suggesting that astrocytic glutamate is
significant in modulating synaptic plasticity.
Conclusions: Our results provide direct evidence for the physiological importance of channel-mediated astrocytic
glutamate in modulating neural circuit functions.
Keywords: Astrocytes, Bestrophin 1, Ca2+-activated anion channel, Synaptic plasticity, Glutamate, NMDA receptor,
LTP, PAR1Background
Growing evidence has supported the idea that astrocytes
are actively involved in modulating synaptic strength by
affecting neuronal properties [1-3]. At glutamatergic
synapses, astrocytically released glutamate has been sug-
gested to play a crucial role in mediating neuronal-glial
circuits. Astrocytes not only clear presynaptically re-
leased glutamates during synaptic transmission, but can
also release glutamate via diverse pathways such as soluble
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unless otherwise stated.exocytosis [4-6] and the glutamate permeable anion
channel [7-11], in response to increased intracellular
Ca2+ concentration by activation of G-protein coupled
receptors expressed at the astrocytic membrane. In
turn, this Ca2+-dependent glutamate release from astro-
cytes can be sensed by presynaptic or postsynaptic glu-
tamate receptors such as the metabotropic glutamate
receptor (mGluR) [6,12] or NMDAR [13,14], both of
which are known to modify presynaptic and postsynap-
tic activities, or synaptic plasticity.
However, the role of astrocytes in synaptic function is
still in question, because recent studies have given
contradictory reports of the involvement of receptor-
mediated Ca2+ signals in astrocytic glutamate release
[15-18]. In order to pinpoint the exact role of astrocyticis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for an effective and reliable tool for triggering glutamate
release from astrocytes. Mounting evidence supports the
ability of PAR1 to trigger the Ca2+-dependent signaling
pathways crucial for astrocytic glutamate release. Acti-
vated by endogenous agonist (thrombin, plasmin) or
TFLLR-NH2 peptide agonist (TFLLR) [19,20], PAR1 can
elevate astrocytic intracellular Ca2+ levels via down-
stream pathways associated with Ca2+ release from in-
ternal stores [19,20]. In addition, PAR1 activation was
shown to be effective for triggering Ca2+-dependent
astrocytic glutamate release when compared with the ac-
tivation by other GPCRs [14,21]. Furthermore, due to se-
lective and functional expression of PAR1 in astrocytes
in the hippocampal CA1 area [20,22], PAR1 signaling
has the additional advantage of inducing astrocyte-
specific Ca2+-dependent signaling in the hippocampal
CA1 area without affecting pre- or postsynaptic neurons.
Therefore, PAR1 appears to be a useful tool for selective
induction of Ca2+-dependent glutamate release from as-
trocytes in vitro and in vivo [10,11,14,20,23-26].
Our previous studies have shown that PAR1 activation
in hippocampal CA1 astrocytes leads to Ca2+-dependent
opening of the glutamate-permeable anion channel,
Best1, which mediates Ca2+-dependent astrocytic glutam-
ate release [8,10,11,26]. Not only does the Best1 channel
displays a glutamate permeability that is Ca2+-dependent
[8], but it also has a preferential subcellular localization
at the microdomains of hippocampal astrocytes located
around synaptic terminals [10]. These studies suggest
that PAR1-induced Ca2+ elevation at the microdomain
directs glutamate release through the Best1 channel,
resulting in an increase in glutamate concentration at
synaptic clefts. Moreover, Best1-mediated astrocytic
glutamate release triggered by PAR1 activation may play
a role in modulating in synaptic plasticity, as recent
studies show that PAR1-deficient mice display reduced
NMDAR-dependent hippocampal LTP and contextual
fear memory [27].
To explore the target and physiological consequences
of Best1-mediated glutamate release from astrocytes, we
triggered Ca2+-dependent glutamate release from hippo-
campal CA1 astrocytes by activating PAR1, and examined
the effect of astrocytic glutamate on neurotransmission.
We demonstrated that synaptic NMDAR is the main tar-
get of astrocytic Best1-mediated glutamate, and increased
synaptic NMDAR activation leads to NMDAR-dependent
potentiation of synaptic transmission. Of equally import-
ance, we also identified an altered NMDAR-dependent
synaptic plasticity at hippocampal synapses, when synaptic
glutamate was increased by Best1-mediated secretion of
glutamate from astrocytes. As well as verifying the func-
tional expression of the mechanism for receptor-mediated
glutamate release in astrocytes, our findings provide directevidence for the involvement of astrocytic anion channel-
mediated glutamate release in synaptic modification.
Results
Astrocytes release glutamate via Best1 channel upon
PAR1 activation
We firstly observed the expression pattern of endogenous
PAR1 at hippocampal Schaffer collateral pathways (SC-CA1
synapses). Immunostaining analysis using PAR1-specific
antibody showed that endogenous PAR1 is selectively
expressed in astrocytes, because ~90% of GFAP-positive
astrocytes showed PAR1 expression (90.0 ± 4.9%, n = 4),
whereas there was no significant expression in neuronal
cells, as shown in previous studies in human and rat brain
(Figure 1A,B) [20,22].
Of more importance, immunohistochemical analysis
by co-staining endogenous PAR-1 and Best1 proteins in
the CA1 area, showed that both PAR1 and Best1 are
highly co-localized in CA1 astrocytes (PAR1/Best1: 79.8 ±
1.6%, n = 10; Best1/PAR1: 80.5 ± 1.6%, n = 10; Figure 1C).
Because the astrocytic Best1 channel is localized at the mi-
crodomain of astrocytic processes near the synaptic region
(Figure 1D) [10], and Ca2+-activated Best1 channel showed
a significant permeability to glutamate in hippocampal as-
trocytes [11], our finding raises a possibility that glutamate
release through Best1 channel at astrocytic microdomains
could affect synaptic glutamate concentration.
To directly test whether PAR1 activation can induce
astrocytic glutamate release through Best1 channel, we
monitored extracellular glutamate by using fluorescence
resonance energy transfer (FRET)-based glutamate sen-
sor GluSnFR (a glutamate-sensing fluorescent reporter)
[28]. This GluSnFR was expressed at the membrane of
CA1 astrocytes in hippocampal slices to detect glutam-
ate released from astrocytes. Control experiments
showed that astrocytic GluSnFR sensors were able to
detect extracellular glutamate in a range from 10−3 to
10−6 M (Figure 1E), similar to that found in cultured
astrocytes [26]. We found that bath application of the
PAR1 agonist, TFLLR (30 μM) [8,20,26] increases extracel-
lular glutamate level (at the peak; 8.5 ± 1.9 μM, n = 5)
around a single CA1 astrocyte, and that this elevation of
extracellular glutamate level was significantly reduced in
slices of Best1 knockout mice (Best1 KO : Figure 1F,G). In
line with previous findings [8,10,11,26], these results indi-
cate that PAR1 activation-triggered astrocytic glutamate
release is mediated by Best1 channels, which possibly per-
meate intracellular glutamate into extracellular synaptic
clefts.
Best1-mediated astrocytic glutamate enhances basal
synaptic transmission
It is possible that basal synaptic transmission at SC-CA1
synapses is modulated by elevated synaptic glutamate
Figure 1 PAR1 activation induces astrocytic glutamate release via Best1. A, Immunohistochemistry images showing endogenous expression
patterns of GFAP (magenta), Best1 (green), PAR1 (red), and nucleus (DAPI in blue) in hippocampal CA1 area. B, Magnified views of the yellow box
in Figure 1A. C, Bar graphs represent the percentage of PAR1-expressing astrocytes among astrocytes showing Best1 expression (PAR1/Best1) or
Best1-expressing astrocytes among astrocytes showing PAR1 expression (Best1/PAR1). Mean ± standard error (s.e.m). Numbers of astrocytes analyzed
are indicated within bars. D, Representative electron microscopy image showing localization of endogenous Best1 in hippocampal CA1 astrocytes.
Po, postsynaptic terminal; Pr, presynaptic terminal. Arrowhead indicates Best1 staining at astrocytic microdomain near synaptic terminals.
E, Above, representative GluSFnR (shown as relative CFP/YFP ratio) in response to bath application of indicated glutamate concentration.
Below, concentration-effect curve representing the averaged peak CFP/YFP ratio (mean ± s.e.m.) induced by application of glutamate at various
concentrations. F, Graph showing the averaged relative CFP/YFP ratio values (mean ± s.e.m.) from time-lapse imaging of GluSFnR-expressing astrocytes
in hippocampal CA1 area of wild type (black) and Best1 knockout (KO) mice (red). Arrowhead indicates the time at which TFLLR puff (30 μM; 500 ms)
was applied. Inset: a representative GluSFnR-expressing hippocampal astrocyte in hippocampal slices. G, Bar graph represents averaged peak amplitudes
of relative CFP/YFP ratio (mean ± s.e.m.) measured from GluSFnR-expressing astrocytes in hippocampal CA1 area of wild type (black) or Best1
knockout (KO) mice. ***, P < 0.005, unpaired two-tailed Student’s t-test. Numbers of tested slices from at least three independent mice are
indicated within each bar.
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exact effect of Best1-mediated astrocytic glutamate on
synaptic transmission, by measuring evoked excitatory
postsynaptic potentials (eEPSPs) at SC-CA1 synapses
(Figure 2A,B). Our data showed that bath treatment of
TFLLR for ~10 min induces an increase in the amplitude
of basal eEPSPs (% baseline, 278.7 ± 37.5, n = 9 slices), and
this potentiated synaptic responses were inhibited by pre-treatment with an antagonist for NMDAR [D-(2R)-amino-
5-phosphonovaleric acid (D-APV), 50 μΜ; % baseline,
120.4 ± 13.4, n = 7 slices; Figure 2C,D]. This suggests that
astrocytic glutamate is able to potentiate basal synaptic
transmission via NMDAR-dependent pathways. TFLLR
application also fails to induce an increase in eEPSP ampli-
tudes from hippocampal slices of Best1 KO mice (% base-
line, 111.1 ± 17.9, n = 7 slices; Figure 2C,D), indicating a
Figure 2 Astrocytic glutamate released upon PAR1 activation induces NMDAR-dependent enhancement of basal EPSP responses at
SC-CA1 synapses via the Best1 channel. A, Schematic diagram showing whole-cell patch clamp measurement of eEPSPs upon Schaffer collateral
(Sch) stimulation recorded from hippocampal CA1 pyramidal neurons (CA1). 30 μM of TFLLR was applied via the bath solution to induce
Ca2+-dependent glutamate release from CA1 astrocytes. A surgical cut was made between CA3 and CA1 (CA3-CA1 cut). DG, dentate gyrus.
B, Representative eEPSP traces recorded from CA1 neurons in naïve slices or slices expressing Best1-shRNA in astrocytes. Black, before TFLLR
application; red, 15 min after TFLLR application. C, Amplitudes of eEPSPs from each recording were normalized to the mean amplitude of
baseline period prior to TFLLR application and shown as averaged relative eEPSPs ± s.e.m. (% Baseline). Graphs represent eEPSP responses
recorded from hippocampal slices of wild type mice treated with control solution (wild type, empty circles) or APV-containing solution (+APV,
black circles), and hippocampal slices of Best1 knockout mice treated with control solution (Best1 KO, grey circles). D, Bar graph representing
mean relative eEPSPs (mean ± s.e.m), analyzed during the period covered by the gray box in C. Bar colors correspond to colours in C. **, P < 0.01, one-way
ANOVA with post-hoc test.
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tic potentiation.
To further investigate whether such synaptic potenti-
ation is specifically mediated by Best1 expressed at as-
trocytes, we adapted a cell-type-specific gene silencing
system to achieve both cell type-specific gene knock-
down and recovery (Figure 3A,B; see also Methods)
[25,29]. We injected a lentivirus containing loxP-floxed
Best1 short-hairpin RNA (shRNA) construct (pSicoR-
Best1-shRNA) into the hippocampal CA1 area of trans-
genic mice expressing tamoxifen-inducible glial fibrillary
acid protein (Gfap) promoter-driven Cre recombinase,Cre (hGFAP-CreERT2) or mice expressing Ca2+/calmodulin-
dependent kinase IIα promoter-driven Cre (CaMKIIα-Cre).
Because loxP-floxed shRNA in the lentiviral construct
can be cleaved by Cre expression in the pSicoR system
[29], delivering a lentiviral particle containing pSicoR-
Best1-shRNA into hGFAP-CreERT2 and CaMKIIα-Cre
transgenic mice allowed us to achieve astrocyte- and
neuron-specific recovery of Best1 expression, respect-
ively (Figure 3C). Using this system, we were also able
to examine the specific effect of astrocytic or neuronal
Best1 on TFLLR-induced potentiation of basal synaptic
transmission.
Figure 3 (See legend on next page.)
Park et al. Molecular Brain  (2015) 8:7 Page 5 of 16
(See figure on previous page.)
Figure 3 Astrocytic Best1 is responsible for PAR1 activation-induced synaptic potentiation. A, A schedule for tamoxifen and lentivirus
injection into hGFAP-CreERT2, wild-type mice (naïve), or CaMKIIα-Cre mice. For acute Cre expression in hGFAP-CreERT2 mice, tamoxifen was
pre-injected for 5 days before lentivirus injection. Sunflower oil, a control for tamoxifen. B, Diagram showing Cre-loxP regulation of shRNA
expression in cell-type specific gene silencing system. In hGFAP-Cre-ERT2 mice, pretreatment of tamoxifen induces Cre expression, leading to
neither shRNA nor EGFP expression in astrocytes through Cre/loxP-mediated deletion. Due to the same mechanism, CA1 pyramidal neurons
cannot express both lentiviral shRNA and EGFP expression in CaMKIIα-Cre mice. C, Left: Representative immunohistochemistry results showing
Cre-dependent regulation of lentiviral shRNA expression. Cre-dependent shRNA expression in astrocytes or neurons was indicated by co-labeling
of EGFP with GFAP or NeuN, respectively. s.p., stratum pyramidale; s.r., stratum radiatum. Scale bar = 50 μm. Right: Bar graphs demonstrate the %
of GFAP/EGFP double positive cells (hGFAP-CreERT2) or EGFP positive cells from GFAP- or NeuN positive cells (CaMKIIα-Cre) among total EGFP
expressing cells. Mean (%) ± s.e.m. ***, p < 0.001, unpaired t-test. Numbers of counted slices at least from three mice were indicated within each
bar. D, eEPSP responses from each recording shown as in Figure 2. Graphs represent averaged eEPSP responses (mean ± s.e.m.) recorded from
loxP-floxed scrambled-shRNA expressing slices from all genotypes. (Sc-sh, empty circles), loxP-floxed Best1-shRNA expressing slices from hGFAP-CreERT2
without [Best1-shRNA (−Tam), black circles] or with tamoxifen [Best1-shRNA (+Tam), light grey circles], and loxP-floxed Best1-shRNA expressing slices
from CaMKIIα-Cre mice [Best1-shRNA (CamKIIα-Cre), dark gray circles]. E, Bar graph representing mean eEPSPs (mean ± s.e.m), analyzed during the
period covered by the gray box in D. Same bar colors as in D. *, P < 0.01, one-way ANOVA with post-hoc test. n.s., not significant.
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expressing Best1-shRNA globally in the CA1 region
(mock-treated hGFAP-CreERT2 mice that were injected
with pSicoR-Best1-shRNA) did not produce a TFLLR-
induced increase in amplitude of eEPSPs (% baseline,
103.9 ± 15.7, n = 7 slices; Figure 3D,E), as observed from
slices of Best1 KO mice (Figure 2C,D). However, when
pSicoR-Best1-shRNA was injected into tamoxifen-
treated hGFAP-CreERT2 mice (to recover Best1 expres-
sion specifically in astrocytes), TFLLR treatment was
sufficient for inducing potentiated eEPSP responses (%
baseline, 202.6 ± 45.0, n = 6 slices; Figure 3D,E). By
contrast, an attempt to rescue Best1 expression in CA1
neurons, by injecting pSicoR-Best1-shRNA into CaMKIIα-
Cre mice that express the Cre recombinase in CA1 pyr-
amidal neurons [30], did not produce eEPSP potentiation
upon TFLLR application (% baseline, 96.6 ± 16.9, n = 7
slices; Figure 3D,E). Together, these data indicate that the
astrocyte-specific Best1 channel is required for enhanced
basal synaptic transmission induced by astrocytic glutam-
ate secretion upon PAR1 activation, implying a role of
Best1-mediated glutamate in modulating synaptic activity.
Best1-mediated astrocytic glutamate elevates synaptic
glutamate
We next explored how astrocytic glutamate may en-
hance synaptic activity. Given the preferential distribu-
tion of astrocytic Best1 channels at microdomains that
wrap around excitatory synaptic structures [10], the glu-
tamate concentration at synaptic clefts may be directly
affected by astrocytic glutamate release.
At excitatory synapses, prolonged decay of evoked
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptor (AMPAR)-mediated excitatory postsynaptic cur-
rents (EPSCs) in the presence of cyclothiazide (CTZ) is
known to closely correlate with elevated glutamate con-
centration at the synaptic cleft [31-33]. By measuring
changes in time constants of the mono-exponential decay
(τdecay) of AMPAR-EPSCs in the presence of CTZ, wetested whether astrocytic glutamate is able to increase the
synaptic glutamate level. In agreement with previous find-
ings [32,33], our own application of CTZ (100 μM) signifi-
cantly increased the peak amplitude and the τdecay of
AMPAR-EPSCs upon Schaffer collateral stimulation
(Figure 4A,B). We found that astrocytic glutamate re-
lease triggered by TFLLR application further increased
the τdecay of CTZ-induced AMPAR-EPSCs with no sig-
nificant change in amplitudes or the coefficient of vari-
ation (CV) of AMPAR-EPSC (Figure 4A,B).
We also showed that the increased τdecay of CTZ-
induced AMPAR-EPSCs by TFLLR application was me-
diated by selective activation of astrocytic PAR1, because
TFLLR application in the presence of CTZ was unable
to induce an increase in τdecay of AMPAR-EPSCs mea-
sured from hippocampal slices of PAR1 knockout mice
(PAR1 KO) (% increase in τdecay, wild type: 52.6 ± 11.6,
n = 5 slices; PAR1 KO: 6.9 ± 7.9, n = 5 slices; Figure 4C,D)
or in mice expressing astrocyte-specific Par1-shRNA
(% increase in τdecay, scrambled shRNA: 68.1 ± 11.8, n = 5
slices; Par1-shRNA: 11.2 ± 28.5, n = 5 slices; Figure 4E-G).
These results indicate that the prolonged activation of syn-
aptic AMPARs is caused by an elevated synaptic glutamate
level that results from astrocytic glutamate upon PAR1 ac-
tivation. To examine whether Best1 channels are required
for the TFLLR-induced increase in synaptic glutamate
concentration, we compared the increased τdecay of
AMPAR-EPSCs by PAR1 activation in Best1 KO hippo-
campal slices with that in wild type slices. Our data
showed that TFLLR application fails to induce an increase
in τdecay of AMPAR-EPSCs from hippocampal slices
of Best1 KO mice as shown in slices of wild type mice
(% increase in τdecay, wild type: 48.4 ± 10.9, n = 10
slices; Best1 KO: 15.6 ± 4.6, n = 7 slices; Figure 4H,I).
Taken together, these results indicate that astrocytic
glutamate released via Best1 channel targets synaptic
clefts, causing an elevated synaptic glutamate concen-
tration when combined with presynaptically released
glutamate.
Figure 4 (See legend on next page.)
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Figure 4 Elevated synaptic glutamate by astrocytic glutamate release. A, Representative AMPAR-EPSCs in the absence (Ctrl) or presence of
CTZ (CTZ), and co-presence of CTZ and TFLLR (CTZ + TFLLR). B, Summary of decay kinetics (τdecay), amplitudes, and coefficient of variation (CV) of
AMPAR-EPSCs (mean ± s.e.m). **, p < 0.01; ***, p < 0.001, one-way ANOVA with post-hoc test. C, Representative traces showing CTZ-induced
changes in AMPAR-EPSCs in wild type (WT) or PAR1 knockout mice (PAR1 KO). D, Summary of increased decay kinetics (τdecay) of AMPAR-EPSCs
by TFLLR application (mean ± s.e.m.). *, p < 0.05, unpaired t-test. E, Above: representative fluorescence image showing expression of Par1 shRNA
in the hippocampal slice of CaMKIIα mice. SR, stratum radiatum. DG, dentate gyrus. The magnified view indicates nonneuronal expression of Par1
shRNA (arrowhead). Below: Western blot analysis showing PAR1 protein level in the naïve hippocampus (Control) or the hippocampus expressing
scrambled-shRNA (SC shRNA) or Par1 shRNA. F, Representative AMPAR-EPSCs, before (CTZ) and after TFLLR application (CTZ + TFLLR), in mice
expressing SC or Par1 shRNA. G, Bar graphs summarizing TFLLR-induced changes in τdecay of CTZ-AMPAR-EPSC. Mean ± s.e.m. *, p < 0.05, unpaired
t-test. H, Representative CTZ-AMPAR-EPSC traces in wild type (WT) or Best1 knockout mice (Best1 KO). I, Summary of TFLLR-induced increases in τdecay
of AMPAR-EPSCs (mean ± s.e.m.). *, p < 0.05, unpaired t-test. J, Representative AMPAR-EPSC traces before (Control) and after TFLLR application (TFLLR).
K, Summary of amplitudes and τdecay of the AMPAR-EPSCs. L, Representative traces showing paired-pulse facilitation (PPF) of AMPAR-EPSCs before
(Control) and after TFLLR application (TFLLR). M, Summary of normalized PPF ratio (% potentiation, mean ± s.e.m.; 2nd EPSC amplitude/1st
EPSC amplitude). IPI, inter-pulse interval. Numbers on the each bar graph indicate the number of tested slices from at least three mice.
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application on amplitudes and τdecay of normal AMPAR-
EPSCs in the absence of CTZ (% amplitude of AMPAR-
EPSCs after TFLLR application = 102.0 ± 7.6, n = 8 slices;
τdecay after TFLLR application = 11.3 ± 1.0 ms, n = 9
slices; Figure 4J,K). In addition, presynaptic release
properties were not affected by astrocyte-mediated in-
creased synaptic glutamate, because PAR1 activation
did not cause any significant alteration in the paired-
pulse facilitation (PPF) of AMPAR-EPSCs (% potenti-
ation; 20 ms IPI, control: 97.3 ± 10.8, TFLLR: 105.2 ±
10.6, n = 4 slices; 50 ms IPI, control: 79.7 ± 11.1, TFLLR:
85.1 ± 11.1, n = 5 slices; Figure 4L,M). These results
suggest that elevated synaptic glutamate level by astro-
cytic glutamate affect neither postsynaptic AMPARs
nor presynaptic glutamate receptors that can regulate
the release probability. In support of this view, our previ-
ous study demonstrated unaltered frequencies and ampli-
tudes of AMPAR-mediated miniature EPSCs (mEPSCs)
upon PAR1 activation [25].
Synaptic NMDARs are activated by Best1-mediated
astrocytic glutamate
Because both presynaptic glutamate receptor and post-
synaptic AMPAR are unaffected by synaptic glutamate
elevation (Figure 4J-M), we next tested whether activity
of synaptic NMDARs could be enhanced by astrocytic
glutamate. We recorded NMDAR-mediated whole-cell
currents at SC-CA1 synapses in the presence of low
external Mg2+ (5 μM) and tetrodotoxin (1 μM), as pre-
viously used for showing that NMDAR-dependent
whole-cell currents can be generated from CA1 neu-
rons by Best1-mediated glutamate released upon PAR1
activation [10].
Our data showed that PAR1 activation effectively in-
creases the amplitude of NMDAR-mediated whole-cell
currents from CA1 pyramidal neurons, whereas treat-
ment with an agonist for other astrocytic native GPCR,
endothelin, did not produce such currents (currentamplitude, tricine control: 9.8 ± 1.9 pA, n = 9 slices;
endothelin: 3.5 ± 2.3 pA, n = 6 slices; Figure 5A,B). A
pretreatment with a GluN2A-specific antagonist (Zn2+;
250 nM), rather than with a GluN2B-specific antagonist
(Ro25-6981; 2 μM) [34,35], was sufficient to eliminate
the NMDAR-mediated currents induced by PAR1 activa-
tion (current amplitue, ZnCl2: 2.0 ± 0.8 pA, n = 12 slices;
Ro25-6981: 12.1 ± 2.3 pA, n = 9 slices; Figure 5A,B), indi-
cating that GluN2A-containing NMDARs is activated by
increased synaptic glutamate. Given that major popula-
tion of synaptic NMDARs contains GluN2A subunits in
mature hippocampal synapses [35], our results suggest
that astrocytic elevation of synaptic glutamate can acti-
vate synaptic NMDARs.
In order to directly examine whether the synaptic
NMDAR activity can be enhanced by astrocytic glutam-
ate, we isolated and measured NMDAR-mediated
evoked EPSPs (NMDAR-EPSP: Figure 5C,D) at SC-CA1
synapses in the presence of 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX) and bicuculline. After TFLLR appli-
cation, the amplitude of evoked NMDAR-EPSPs was
gradually increased (% baseline after TFLLR application:
144.2 ± 18.6%, n = 7 slices; Figure 5C,D), consistent with
the idea that the activity of synaptic NMDAR is in-
creased by astrocytic synaptic glutamate elevation.
When opened synaptic NMDARs during synaptic
transmission were fully blocked by bath application
with MK-801 (50 μM; Figure 5C), we could not detect
any increase in amplitude of NMDAR-EPSP on TFLLR
application (% baseline after TFLLR application: 87.1 ±
11.3%, n = 7 slices; Figure 5C,D). Together with evi-
dence for the direct activation of GluN2A-sensitive
NMDAR by astrocytic glutamate (Figure 5A,B), these
results support the notion that GluN2A-containing
synaptic NMDARs are the major target of astrocytic
glutamate, and our observation of NMDAR-dependent
synaptic strengthening is resulted from increased acti-
vation of synaptic NMDARs by astrocytic synaptic glu-
tamate elevation (Figure 2).
Figure 5 Astrocytic glutamate released upon PAR1 activation targets GluN2A-containing synaptic NMDARs. A, Representative recording
traces indicating NMDAR-dependent whole-cell currents measured from a CA1 pyramidal neuron induced by the treatment with TFLLR(for PAR1)
or endothelin (for endothelin receptor), in the presence of GluN2A (ZnCl2) or GluN2B-specific antagonist (RO25-6981). The arrow and dotted lines
indicate the current responses before and after agonist treatments. B, Bar graph summarizing the averaged amplitudes of NMDAR-dependent
currents induced by astrocytic glutamate (mean ± s.e.m). Numbers of tested slices from at least three independent mice are indicated within each
bar. *, p < 0.05, unpaired two-tailed Student’s t-test. C, Upper: representative NMDAR-eEPSP responses (isolated by co-application of 20 μM CNQX
and 5 μM bicuculline) measured from CA1 pyramidal neuron, before (1) and after (2) TFLLR treatment in the absence of MK-801, and before (3)
and after (4) TFLLR treatment in the presence of MK-801. Gray traces indicate NMDAR-eEPSP before TFLLR application in each experimental
condition. Lower: representative time course of the amplitude of NMDAR-eEPSPs from a single CA1 pyramidal neuron. Numbers (1) to (4) represent the
same as those in the Upper section. D, Bar graph comparing normalized amplitudes of NMDAR-eEPSPs after TFLLR treatment with those before TFLLR
treatment (% of control by TFLLR; mean ± s.e.m.). Numbers of tested slices from at least three independent mice are indicated within each
bar. *, p < 0.05, unpaired two-tailed Student’s t-test.
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plasticity
We next asked whether long-term synaptic plasticity at
SC-CA1 synapses could be modulated by astrocytic glu-
tamate, because hippocampal synaptic plasticity are
dependent on NMDAR-dependent Ca2+ signaling [36].
To examine the possible involvement of astrocytic glu-
tamate in synaptic plasticity, we measured the effect of
astrocytic PAR1 activation on the magnitude of long-
term potentiation/depression (LTP/LTD) that were in-
duced by electrical stimulation at various frequencies
[1 Hz, 10 Hz, and theta-burst stimulation (TBS)] to
Schaffer collateral fibers in hippocampal slices. Our field
EPSP (fEPSP) recording measurements showed that the
magnitude of LTD induced by either 1 Hz- or 10 Hz-
stimulation in the presence of TFLLR was significantly
lower than that in the absence of TFLLR (ACSF-treated)
(% baseline, 1 Hz: 72.1 ± 5.5, n = 6 slices; 1 Hz + TFLLR:84.8 ± 2.1, n = 11 slices; 10 Hz: 77.8 ± 2.7, n = 5 slices;
10 Hz + TFLLR: 86.9 ± 2.7, n = 8 slices Figure 6A,B,D).
However, the magnitude of TBS-induced LTP in the
presence of TFLLR was higher than that in the absence
of TFLLR (% baseline, TBS: 122.8 ± 2.6, n = 11 slices;
TBS + TFLLR: 131.9 ± 3.1, n = 10 slices; Figure 6C,D).
Since the TFLLR treatment had no effect on presynap-
tic properties (Figures 4M, 6E), these altered changes
in fEPSP responses by PAR1 activation appear to be
mediated by postsynaptic mechanisms that include
NMDAR-dependent signaling.
On the other hand, selective activation of astrocytic
GPCR, Mas-related G-protein coupled receptor member
A1 (MrgA1) by applying its agonist, FMRFamide peptide
(FMRFa; ~ 30 min), to hippocampal slices of transgenic
mice selectively expressing MrgA1 in astrocytes [16],
was not efficient for altering fEPSP responses (Figure 6F).
Moreover, in contrast to PAR1 activation, MrgA1
Figure 6 Modulation of hippocampal synaptic plasticity by PAR1-induced glutamate release from astrocytes. A-C, The magnitude of LTD
induced by 1 Hz stimulation (A) and 10 Hz stimulation (B), or LTP induced by theta-burst stimulation (C) in the absence (ACSF; black circles) or
presence of TFLLR (TFLLR; white circles). Numbers of tested slices from at least three independent mice are indicated. D, Graph summarizing data
in A-C by representing averaged fEPSP responses (mean ± s.e.m.) 50 ~ 60 min after application of each stimulation condition in the absence
(ACSF; black circles) or presence of TFLLR (TFLLR; white circles). *, p < 0.05, unpaired Student’s t-test. E, Summary of paired-pulse facilitation (PPF)
ratio of fEPSP responses in the absence (ACSF; black circles) or presence of TFLLR (TFLLR; white circles). ISI, inter-stimulus interval. The n numbers
indicated for each group are the number of tested slices from at least five mice. F, Summary of basal fEPSP responses induced by treatment of
either TFLLR to hippocampal slices of wild type mice (TFLLR) or FLRFamide to hippocampal slices of MrgA1 transgenic mice (MrgA1/FLRF) during
the period indicated as a black line. G, Summary of LTD induction by applying 1 Hz (900 stimuli) to hippocampal slices of MrgA1 transgenic mice
in the absence (MrgA1/ACSF; black circles) or presence of FLRFamide (MrgA1/FLRF; empty circles). H, Bar graph representing averaged % baseline
of fEPSPs (mean ± s.e.m.) 50 ~ 60 min after stimulation. Numbers of tested slices from at least three independent mice are indicated within each
bar. P = 0.780, unpaired two-tailed Student’s t-test.
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magnitude of LTD compared with control (% baseline,
MrgA1: 86.9 ± 5.2, n = 5 slices; MrgA1 + FLRF: 89.5 ± 7.8,
n = 4 slices; Figure 6G,H). These data are in agreementwith previous reports showing that an increase in astro-
cytic Ca2+ by MrgA1 activation is not linked to the
mechanisms responsible for triggering astrocytic glutam-
ate release [15,16].
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activity by astrocytic glutamate might affect LTP in-
duction. Due to preferential targeting of astrocytic glu-
tamate to synaptic NMDARs, we predicted that normal
NMDAR-dependent LTP could be induced when sub-
threshold electrical stimulation for LTP induction is
combined with astrocytic synaptic glutamate elevation.
We found that neither subthreshold electrical stimula-
tion (40 Hz, 10 stimuli: Figure 7A) nor a short period
of TFLLR application (less than ~7 min) to the hippo-
campal slices was sufficient for inducing synaptic po-
tentiation when treated alone (% baseline, 40 Hz alone:
95.0 ± 5.3, n = 5 slices; TFLLR alone: 92.4 ± 5.7, n = 5
slices; Figure 7A,B). However, combined application of
subthreshold stimulation with TFLLR (40 Hz + TFLLR)
was effective in inducing LTP that was sensitive to
pretreatment with APV or an anion channel blocker,
niflumic acid (NFA; 100 μM) (% baseline, 40 Hz +
TFLLR: 131.65 ± 10.6, n = 9 slices; 40 Hz + TFLLR +
NFA: 101.0 ± 5.6, n = 6 slices; Figure 7A,B). To test
whether this LTP requires Best1-mediated glutamate,
we measured 40 Hz + TFLLR-induced LTP responses
from hippocampal slices, of which Best1 gene expres-
sion was manipulated in a cell-type specific manner as
performed previously (see Figure 3). We found that 40
Hz + TFLLR-induced LTP is significantly prevented by
general expression of Best1 shRNA in the hippocampal
CA1 area (slices from mock-treated hGFAP-CreERT2
mice injected with pSicoR-Best1-shRNA), whereas hip-
pocampal slices with astrocyte-specific rescue of Best1
expression (from tamoxifen-treated hGFAP-CreERT2 mice
injected with pSicoR-Best1-shRNA) showed 40 Hz +
TFLLR-induced LTP comparable to that from the same
transgenic mice injected with scrambled-shRNA (Sc-
shRNA) (% baseline, Sc-shRNA: 131.3 ± 8.8, n = 7 slices;
Best1-shRNA w/o taxmoxifen: 101.1 ± 5.5, n = 7 slices;
Best1-shRNA w/tamoxifen: 115.43 ± 3.9, n = 9 slices;
Figure 7C,D). These results indicate that glutamate re-
leased via the Best1 channel in CA1 astrocytes is re-
quired for NMDAR-dependent LTP induced by the 40
Hz +TFLLR stimulation. In accordance with these findings,
neuron-specific rescue of Best1 expression (CaMKIIα-Cre
mice with pSicoR-Best1–shRNA) failed to induce LTP with
the 40 Hz +TFLLR stimulation (% baseline, Sc-shRNA:
125.5 ± 7.2, n = 8 slices; Best1-shRNA: 96.2 ± 6.4, n = 9
slices; Figure 7E,F). As a whole, our data show that
glutamate released via astrocytic Best1 plays a significant
role in modulating synaptic plasticity by lowering the
threshold for LTP induction.
Discussion
Our study reveals the physiological potential for recep-
tor-mediated and channel-dependent astrocytic glutam-
ate release in synaptic function. This action is mediatedby the mechanism initiated by astrocytic GPCR acti-
vation that can lead to glutamate secretion via the
Ca2+-activated anion channel (Best1) in astrocytes
(Figure 8). We provide direct evidence that GluN2A-
containing postsynaptic NMDAR is the main glutam-
ate receptor sensing astrocytic glutamates or elevated
synaptic glutamate levels (Figure 5A,B). Because acti-
vation of GluN2-containing NMDARs is dependent
on the depolarization-induced removal of Mg2+ block
[37], binding of astrocytic glutamate to synaptic NMDARs
may permit increased NMDAR opening when coincident
postsynaptic depolarization is accompanied during spon-
taneous or evoked synaptic transmission (Figure 8). In-
creased NMDAR activation from the participation of
astrocytic glutamate would lead to elevated Ca2+ influx
into postsynaptic sites and in turn trigger diverse sig-
naling pathways responsible for synaptic strengthening
(Figure 8).
Consistent with previous reports [14,15,17,38], activa-
tion of astrocytic GPCRs, with the exception of PAR1,
was not sufficient to trigger glutamate release from as-
trocytes (Figures 6F and 7A), supporting the idea that
glutamate released upon astrocytic PAR1 activation has
a specific modulatory role in synaptic function. The rea-
son that PAR1 is more effective than other GPCRs for
inducing glutamate release from astrocytes remains to
be determined, but it is possible that activation of
MrgA1 or other GPCRs only causes an insufficient Ca2+
levels at microdomains for triggering Ca2+-dependent
glutamate release mechanisms [38]. On the other hand,
either MrgA1 or other GPCRs may not be associated
with the astrocytic molecular mechanisms responsible
for glutamate release, whereas PAR1 is linked to mul-
tiple channel-mediated glutamate release mechanisms
such as G protein-dependent opening of the two-pore K+
channel (TREK-1) and Ca2+-dependent opening of the
Best1 channel [10]. Thus, if PAR1 activation occurs during
the process of synaptic plasticity, astrocytic glutamate
released through channel-mediated mechanisms may
play a significant role in modulating hippocampal syn-
aptic plasticity and cognitive functions. In support of
this idea, it has been shown that activation of PAR1 by
thrombin (a native PAR1 agonist) or TFLLR modulates
LTP formation at hippocampal synapses [27,39], and
that a reduction in NMDAR-dependent hippocampal
LTP and contextual fear memory were observed in
PAR1 deficient mice [27]. How astrocytic PAR1 is acti-
vated during the process of synaptic plasticity and
memory formation is still unclear, but we suggest that
astrocytic PAR1 might be activated by endogenous PAR1
agonists that are generated from secreted proteases or
their byproducts in an activity-dependent manner. For ex-
ample, plasmin, which is cleaved from plasminogen by the
extracellular tissue plasminogen activator (tPA), can act as
Figure 7 (See legend on next page.)
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Figure 7 A combination of subthreshold synaptic stimulation and Best1-mediated astrocytic glutamate produces NMDAR-dependent
LTP at SC-CA1 synapses. A, Summary of LTP recordings in hippocampal slices when subthreshold stimulation (40 Hz) with TFLLR (40 Hz + TFLLR;
black circles), 40 Hz alone (40 Hz; white circles), TFLLR alone (TFLLR; gray circles), 40 Hz with TFLLR in the presence of APV (40 Hz + TFLLR + APV; green
circles) or niflumic acid (40 Hz + TFLLR + NFA; red circles), and 40 Hz with endothelin (Endothelin; blue circles) was applied. B, Bar graph representing
the averaged % baseline of fEPSPs (mean ± s.e.m.) over the time period indicated by the gray bar in A. *, p < 0.05, one-way ANOVA with post-hoc test.
Same colors as A. Numbers of tested slices from at least three mice are indicated within each bar. C, Summary of LTP recording from loxP-floxed
scrambled-shRNA expressing hippocampal slices (Sc-shRNA, black circles), loxP-floxed Best1-shRNA expressing slices from hGFAP-CreERT2 mice
without [Best1-shRNA (−Tam), white circles] or with tamoxifen pretreatment [Best1-shRNA (+Tam), gray circles]. D, Bar graph representing the
averaged % baseline of fEPSPs (mean ± s.e.m.) over the time period indicated by the gray bar in C. *, p < 0.05, one-way ANOVA with post-hoc
test. Same colors as C. Numbers of tested slices from at least three mice are indicated within each bar. E, Summary of LTP recording from
Sc-shRNA expressing hippocampal slices (black circles) or Best1-shRNA expressing slices from CaMKIIα-Cre mice (white circles). F, Bar graph
representing the averaged % baseline of fEPSPs (mean ± s.e.m.) over the time period indicated by the gray bar in E. *, p < 0.05, unpaired
t-test. Same colors as E. Numbers of tested slices from at least independent mice are indicated within each bar.
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activity-dependent secretion of tPA from postsynaptic
dendrites [40,41] is required for inducing late-phase LTP
(L-LTP) at hippocampal synapses [42,43].
Our study has also provided evidence for the involve-
ment of PAR1-triggered astrocytic glutamate in synaptic
function by showing that the Best1 channel is required
for synaptic NMDAR activation. Ultrastructural analyses
showed that Best1 channels are preferentially expressed
at the membrane of astrocytic microdomains around
synaptic terminals in the hippocampus (Figure 1), pro-
posing a possible influence of Best1-mediated glutamateFigure 8 Schematic diagram of proposed physiological roles for Ca2+
synaptic plasticity. We propose a model for the modulation of synaptic fu
postsynaptic NMDARs. A, Astrocytic GPCR is activated by neurotransmitter
of Ca2+ from internal stores, resulting in an increase in intracellular Ca2+ conce
C, Increased microdomain Ca2+ activates the Ca2+-dependent glutamate-perm
D, Best1-mediated glutamate binds to synaptically localized NMDAR (GluN2A)
causes postsynaptic depolarization. F, When postsynaptic depolarization resul
glutamate to synaptic NMDARs, Ca2+ influx to postsynaptic sites is increa
increasing synaptic strength.on the synaptic glutamate level [10]. Consistent with
this, we have shown that PAR1 activation prolongs the
CTZ-induced AMPAR-EPSC response, an action indica-
tive of increased synaptic glutamate levels, and that this
prolonged AMPAR-EPSC response was dependent on
Best1 expression (Figure 4). Because the amount of glu-
tamate released through the Best1 channel was much
lower (10−5 ~ 10−6 M; Figure 1E-G) than that from pre-
synaptically released glutamate (~10−3 M), a subtle in-
crease in synaptic glutamate levels by PAR1 activation
thus had no significant effect on synaptic glutamate re-
ceptors, other than NMDARs [2,20,39], as shown by the-dependent astrocytic glutamate release via Best1 channel in
nction via the action of astrocytic Best1-mediated glutamate on
or neuronal factors. B, Downstream signaling pathways induce release
ntration ([Ca2+]i) at microdomains that wrap around synaptic terminals.
eable anion channel (Best1), leading to glutamate efflux from astrocytes.
. E, Glutamate released from presynaptic neuron activates AMPAR, which
ting from synaptic activity is accompanied by the binding of astrocytic
sed, resulting in the enhanced Ca2+-dependent signaling required for
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mediated postsynaptic activity (Figure 4J-M). Thus, we
suggest that enhanced NMDAR-dependent signaling by
receptor-mediated astrocytic glutamate release can pro-
duce potentiation of AMPAR-mediated synaptic trans-
mission (Figure 2), because AMPAR expression at the
postsynaptic membrane could be elevated by activation
of NMDAR-dependent signaling [44,45]. However, our
study do not exclude the possibility that astrocytic
modulation of synaptic NMDAR activity and neuro-
transmission is mediated by other active substances such
as D-serine [46,47], which might be released through
Best1 channels in astrocytes. Further studies are re-
quired for clarifying the role of astrocytes in modulating
neural circuits and behaviors by dissecting the exact
functions of Best1 channels in neurotransmission.Conclusions
In summary, our present study reveals that astrocytes can
play a significant role in regulating neural synaptic func-
tions, by releasing glutamate via Ca2+-activated anion
channels opened by the activation of receptor-mediated
signaling. The models proposed and the tools developed
in this study aim to improve our understanding of the
physiological role of multiple glutamate release mecha-
nisms, along with their significance in cognitive functions.Methods
Ethical approval
All animal protocols were performed in accordance with
the institutional guideline of Korea institute of Science
and Technology (KIST; Seoul, Korea).FRET-based glutamate imaging
The amount of released extracellular glutamate was rep-
resented by the ratio between the emission intensity of
CFP and YFP (CFP/YFP), which was divided by baseline
CFP/YFP ratio (relative CFP/YFP ratio). Adenovirus
containing pDisplay-GluSnFR [28] was injected into the
hippocampal CA1 region. After one week, FRET im-
aging in acute hippocampal slices was performed under
a microscope (BX50WI; Olympus) equipped with a xenon
lamp fitted with a 436/20-excitation filter (D436/20x filter;
Chroma). The emission beam was split using a Dual-View
(Optical Insights) fitted with a CFP/YFP filter set (OI-05-
EX), and recorded with an iXon EMCCD camera (Andor).
Imaging Workbench software (INDEC BioSystems) was
used for image acquisition and offline image analysis.
TFLLR puffs (TFLLR-NH2; Peptron, Korea; 500 μM)
were applied using picospritzer-assisted positive pres-
sure (~100 ms).Production of shRNA containing lentivirus and delivery
into mouse hippocampus
Scrambled shRNA, mBest1-shRNA, and Par1-shRNA
were inserted into pSicoR lentiviral vector (provided by
Dr. T. Jacks through Addgene Inc.; [29] as previously de-
scribed [8]. For shRNA expression in hippocampal CA1
region, lentivirus (produced by Macrogen, Korea) was
introduced into the hippocampal CA1 region by the
stereotaxic surgery method [48]. hGFAP-CreERT2 trans-
genic mice were provided by Dr. Ken McCarthy.
CaMKIIα-Cre transgenic mice were purchased from The
Jackson Laboratory. hGFAP-CreERT2 mice were used at
the age of 7 weeks for tamoxifen or sunflower oil injec-
tion (intraperitoneal injection, once per day for 5 days).
The lentivirus carrying shRNA was injected 1 day after
the fifth day injection. CaMKIIα-Cre mice were used at
8 weeks of age for virus injection and were used at
around 9 weeks for electrophysiological recordings. Only
male mice were used throughout the study. Injected
mice were sacrificed for electrophysiological recordings
at 8 ~ 9 weeks of age.
Slice preparation and electrophysiology
Horizontal or transverse mouse brain slices (300 ~
400 μm) containing hippocampus were acutely prepared
as previously described [20]. Prepared slices were left to
recover for at least 1 hour before recording, in oxygen-
ated (95% O2 and 5% CO2) artificial cerebrospinal fluid
(ACSF; in mM, 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25
NaH2PO4, 1 CaCl2, 3 MgCl2 and 10 glucose, pH 7.4;
room temperature). The standard ACSF recording solu-
tion was composed of (mM): 130 NaCl, 24 NaHCO3, 3.5
KCl, 1.25 NaH2PO4, 1.5 CaCl2, 1.5 MgCl2 and 10 glu-
cose saturated with 95% O2 and 5% CO2, at pH 7.4. To
block the effect of neuronal spontaneous activity on as-
trocytes, TTX (0.5 μM; Tocris Bioscience) was added
into the ACSF. Experiments with a holding current of
more than −100 pA or in which there was a change in
input resistance >30% of the control were rejected.
Recordings were obtained using Axopatch 200A
(Axon Instruments) and were filtered at 2 kHz.
mEPSC recordings were digitized at 10 kHz and ana-
lyzed using pCLAMP 9 software (Axon Instruments)
and Mini Analysis Program software (Synaptosoft) as
previously described [20]. Whole-cell recordings from
CA1 neuron, mEPSC recordings, and eEPSP recordings
were carried out as previously described [20]. For making
Zn-included ACSF solution, 250 nM ZnCl2 was used in
10 mM Tricine with the relation [Zinc]free = [Zinc]applied/
200 as previously described [34,35]. CA1 fEPSPs were
evoked by Schaffer collateral using a bipolar electrode and
quantified as the initial slope of fEPSP as previously de-
scribed [49]. To examine the effect of TFLLR on synaptic
plasticity at different stimulation frequencies, slices were
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Electrical stimulations were given as 1 Hz (900 sec), 10 Hz
(90 sec), and theta-burst stimulation (consisting of four
trains containing ten bursts (each with four pulses at
100 Hz) of stimuli delivered every 200 msec). For 40 Hz +
TFLLR-induced LTP induction experiments, TFLLR
(30 μM) was applied ~8 min before 40 Hz stimulation and
washed out 2 min after stimulation. APV (Tocris Bio-
science; 50 μM), niflumic acid (Sigma; 100 μM) was co-
treated with TFLLR.
Immunohistochemistry
Adult mice were deeply anesthetized with 2% avertin
and perfused with 0.1 M PBS followed by 4% parafor-
maldehyde. Brains were postfixed in 4% paraformalde-
hyde at 4°C for 24 hr and 30% sucrose at 4°C for 48 hr.
Brains were then cut into 30 μm coronal cryosections.
Sections were blocked in 0.1 M PBS containing 0.3%
Triton X-100 (Sigma) and 2% Donkey Serum (GeneTex)
for 30 min at room temperature. Primary antibody was
then applied at the appropriate dilution and incubated
overnight at 4°C. Sections were then washed three times
in 0.1 M PBS and incubated in secondary antibody for
2 h. After three rinses in 0.1 M PBS and DAPI staining
at 1:1000 (Pierce), the sections were mounted on poly-
sine microscopic glass slides (Thermo Scientific). Images
were acquired using a Nikon A1R confocal microscope.
Electron microscopy
Animals were deeply anesthetized with sodium pento-
barbital (80 mg/kg, i.p.) and perfused transcardially with
heparinized normal saline (10 ml for mouse and 100 ml
for rat), followed by a freshly prepared mixture (50 ml
for mouse and 500 ml for rat) of 4% paraformaldehyde
and 0.01% glutaraldehyde in 0.1 M phosphate buffer
(PB), pH 7.4. Hippocampus was removed and postfixed
in the same fixative for 2 hours at 4°C. Sagittal sections
(60 μm) were cut with a vibratome and cryoprotected in
30% sucrose in PB overnight at 4°C. Sections were frozen
on dry ice for 20 minutes, thawed in phosphate-buffered
saline (PBS; 0.01 M, pH 7.2) to enhance penetration.
They were pretreated with 1% sodium borohydride for
30 minutes to quench glutaraldehyde and then blocked
with 3% H2O2 for 10 minutes to suppress endogenous
peroxidases, and with 10% Normal Donkey Serum (NDS,
Jackson ImmunoResearch, West Grove, PA) for 30 minutes
to mask secondary antibody binding sites. For double im-
munostaining of GFP and Best1, sections of hippocampus
pretreated as above were incubated overnight in a mixture
of mouse anti-GFP (1:400, MAB3580, Millipore, Temecula,
CA) and rabbit anti-Best1 (1:200) antibodies. After rinsing
in PBS, sections were incubated with a mixture of biotinyl-
ated donkey anti-mouse (1:200, Jackson ImmunoResearch)
and 1 nm gold-conjugated donkey anti-rabbit (1:50,EMS, Hatfield, PA) antibodies for 2–3 hours. The
sections were postfixed with 1% glutaraldehyde in PB
for 10 minutes, rinsed in PB several times, incubated
for 4 minutes with HQ silver enhancement solution
(Nanoprobes, Yaphank, NY), and rinsed in 0.1 M so-
dium acetate and PB. Serially cut thin sections were
collected on Formvar-coated single slot nickel grids
and stained with uranyl acetate and lead citrate. Grids
were examined on a Hitachi H-7500 electron micro-
scope (Hitachi, Tokyo, Japan) at 80 kV accelerating volt-
age. Images were captured with Digital Montage software
driving a MultiScan cooled CCD camera (ES1000W,
Gatan, Pleasanton, CA) attached to the microscope and
saved as TIFF files.
Statistical analyses
All data were shown as mean ± standard error of the
mean (s.e.m.). Statistical analyses were performed by
using Sigma Plot software (ver. 10.0; Systat Software
Inc., San Jose, CA). Detailed information of the statistical
tests was indicated in the figure legends.
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